CENTOGENElogo.jpg
CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
August 20, 2020 01:30 ET | CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and HAMBURG, Germany and BERLIN, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that...
CENTOGENE Opens Walk-In COVID-19 Testing Facility at Hamburg Airport
August 19, 2020 02:00 ET | CENTOGENE GmbH
CENTOGENE expands its SARS-CoV-2 testing solution to Hamburg Airport after successfully launching the first walk-in COVID-19 test facility at Frankfurt Airport in June 2020 in cooperation with...
CENTOGENElogo.jpg
CentoMD® Update Reveals Further Insights Into Rare Diseases
August 11, 2020 06:30 ET | CENTOGENE GmbH
CAMBRIDGE, Mass., and ROSTOCK and BERLIN, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and...
CENTOGENElogo.jpg
CENTOGENE Supports Tajikistan in Fight Against the COVID-19 Pandemic
August 04, 2020 06:30 ET | CENTOGENE GmbH
CENTOGENE expands ongoing development cooperation with Ministry of Health and Social Protection of the Population of Tajikistan (MoH) to now include COVID-19 testingThe project supports access to...
CENTOGENElogo.jpg
CENTOGENE and Molecular Health Announce an Exclusive Collaboration With the Aim to Transform the Development of Orphan Drugs
July 27, 2020 08:00 ET | CENTOGENE GmbH
The combination of real-life data sets in rare diseases with innovative big data/artificial intelligence/novel scientific computational knowledge will transform biomedical research, product...
CENTOGENElogo.jpg
CENTOGENE Announces Convenient At-Home Coronavirus Test Solution Now Available in Germany on Online Marketplace
July 23, 2020 02:30 ET | CENTOGENE GmbH
CENTOGENE announces test kits for the detection of SARS-CoV-2 virus RNA now available on Amazon in Germany ─ the first of its type offered on the online marketplaceOffering includes delivery of a...
CENTOGENElogo.jpg
CENTOGENE Announces Pricing of Primary and Secondary Public Offering of Common Shares
July 09, 2020 19:19 ET | CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases...
CENTOGENElogo.jpg
CENTOGENE Announces the Scientific Publication of a holistic solution in the preventive testing of COVID-19
July 09, 2020 06:30 ET | CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics and genetic research company, today announced that...
CENTOGENElogo.jpg
CENTOGENE Announces Proposed Primary and Secondary Public Offering of Common Shares
July 07, 2020 18:16 ET | CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
CENTOGENElogo.jpg
CENTOGENE Announces Partnership with OESIS Network for COVID-19 PCR Testing for US School Populations
July 06, 2020 06:30 ET | CENTOGENE GmbH
CAMBRIDGE, Mass. and SANTA MONICA, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics and genetic research company, and the OESIS Network Inc, an...